Literature DB >> 11334847

Uptake mechanism of valproic acid in human placental choriocarcinoma cell line (BeWo).

F Ushigome1, H Takanaga, H Matsuo, K Tsukimori, H Nakano, H Ohtani, Y Sawada.   

Abstract

Valproic acid is an anticonvulsant widely used for the treatment of epilepsy. However, valproic acid is known to show fetal toxicity, including teratogenicity. In the present study, to elucidate the mechanisms of valproic acid transport across the blood-placental barrier, we carried out transcellular transport and uptake experiments with human placental choriocarcinoma epithelial cells (BeWo cells) in culture. The permeability coefficient of [3H]valproic acid in BeWo cells for the apical-to-basolateral flux was greater than that for the opposite flux, suggesting a higher unidirectional transport in the fetal direction. The uptake of [3H]valproic acid from the apical side was temperature-dependent and enhanced under acidic pH. In the presence of 50 microM carbonyl cyanide p-trifluoromethoxylhydrazone, the uptake of [3H]valproic acid was significantly reduced. A metabolic inhibitor, 10 mM sodium azide, also significantly reduced the uptake of [3H]valproic acid. Therefore, valproic acid is actively transported in a pH-dependent manner on the brush-border membrane of BeWo cells. Kinetic analysis of valproic acid uptake revealed the involvement of a non-saturable component and a saturable component. The Michaelis constant for the saturable transport (K(t)) was smaller under acidic pH, suggesting a proton-linked active transport mechanism for valproic acid in BeWo cells. In the inhibitory experiments, some short-chain fatty acids, such as acetic acid, lactic acid, propanoic acid and butyric acid, and medium-chain fatty acids, such as hexanoic acid and octanoic acid, inhibited the uptake of [3H]valproic acid. The uptake of [3H]valproic acid was also significantly decreased in the presence of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, salicylic acid and furosemide, which are well-known inhibitors of the anion exchange system. Moreover, p-aminohippuric acid significantly reduced the uptake of [3H]valproic acid. These results suggest that an active transport mechanism for valproic acid exists on the brush-border membrane of placental trophoblast cells and operates in a proton-linked manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334847     DOI: 10.1016/s0014-2999(01)00912-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Valproic acid stimulates in vitro migration of the placenta-derived mesenchymal stem/stromal cell line CMSC29.

Authors:  Balta Al-Sowayan; Rosemary J Keogh; Mohammed Abumaree; Harry M Georgiou; Bill Kalionis
Journal:  Stem Cell Investig       Date:  2019-02-13

3.  Valproate, thalidomide and ethyl alcohol alter the migration of HTR-8/SVneo cells.

Authors:  Ujjwal K Rout
Journal:  Reprod Biol Endocrinol       Date:  2006-08-21       Impact factor: 5.211

4.  The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts.

Authors:  Hana Polachek; Nir Debotton; Valeria Feinshtein; Mazal Rubin; Zvi Ben-Zvi; Gershon Holcberg; Riad Agbaria; Arik Dahan
Journal:  Drug Des Devel Ther       Date:  2018-12-04       Impact factor: 4.162

5.  Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis.

Authors:  Asmita Gyawali; Sana Latif; Seung-Hye Choi; Seung Jae Hyeon; Hoon Ryu; Young-Sook Kang
Journal:  J Biomed Sci       Date:  2022-01-10       Impact factor: 8.410

6.  Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner.

Authors:  Kelly A Foley; Klaus-Peter Ossenkopp; Martin Kavaliers; Derrick F Macfabe
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.